Journal
EXPERT REVIEW OF ANTICANCER THERAPY
Volume 8, Issue 9, Pages 1449-1460Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/14737140.8.9.1449
Keywords
esophageal neoplasm; esophagectomy; intraoperative complication; laparoscopy; minimally invasive surgery; survival; thoracoscopy; video-assisted thoracoscopic surgery
Categories
Ask authors/readers for more resources
Esophagectomy is an important component in the comprehensive treatment of esophageal cancer The 5-year survival in patients who are treated with esophagectomy is approximately 35% compared with approximately 16% for all patients. However, esophagectomy is a complex operation with high (40-60%) morbidity and 5-20% mortality rates reported by many centers. Minimally invasive approaches to esophagectomy have been developed over the past decade-potential advantages of minimally invasive esophagectomy (MIE) include a reduced risk of perioperative morbidity and mortality with equivalent oncologic outcomes, including extent of lymphadectomy and survival. However, significant debate still exists regarding the role of MIE in the treatment of esophageal cancer, particularly given the limitations in the widespread implementation of this technically challenging operation. This review summarizes the current status of the use of minimally invasive surgery in treating esophageal cancer and seeks to answer the question of whether MIE is indicated in the treatment of esophageal cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available